sözaltı news Finance
Finance
EN AZ
Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

marketwatch.com 30.09.2026 16:32 40 views
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.
Related stories
China’s nightmare: becoming the next Japan
China’s nightmare: becoming the next Japan
ft.com · 21.10
 Australian data centre group falls 44% on profit warning
Australian data centre group falls 44% on profit warning
ft.com · 21.10
 OpenAI ‘agents’ disabled their own monitoring systems
OpenAI ‘agents’ disabled their own monitoring systems
ft.com · 21.10
 The tech helping crack decades-old cold cases
The tech helping crack decades-old cold cases
bbc.co.uk · 21.10
 Why SpaceX’s stock is surging — and lifting the broader AI universe along with it
Why SpaceX’s stock is surging — and lifting the broader AI universe along with it
marketwatch.com · 21.10
 Super Micro’s stock soars after surprise update — with Dell and HPE shares joining the rally
Super Micro’s stock soars after surprise update — with Dell and HPE shares joining the rally
marketwatch.com · 21.10